
Lifestyle
Mounjaro Is Now India’s Top-Selling GLP-1 Drug: What the ₹2,333 Crore Market Shift Shows
Mounjaro has emerged as the biggest-selling brand in India’s fast-growing GLP-1 medicines market, while the overall segment reached ₹2,333 crore in value for the 12 months ended August.